Case Report

Sedation-Paralysis as Cornerstone on Rabies Management (Milwaukee Protocol)


Rabies is a viral infection involving the central nervous system that is almost always fatal without proper post exposure prophylaxis. Here, we present a 38 years-old male with dog-bite and late attention whom, managed in intensive care unit. After 21 days, the disease progressed to serious neurologic and hemodynamic damage including motor disorders and imbalance in blood pressure and cardiac rhythm. Clinical management of the patient consisted of antiviral agents (Amantadine and Ribavirin), neuroprotection, sedation-paralysis and supportive care. Patient was survived 43 days from the clinical disease onset. Although our patient died in spite of intensive care, advances in the use of sedation-paralysis and early prescription of antiviral agents raised hopes that it may eventually be possible to save rabies patients.

[1] Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 2002;1(2):101-9.
[2] Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol. 2006;12(5):407-9.
[3] Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis. 2010;50(1):56-60.
[4] Willoughby Jr RE, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508-14.
[5] Jackson AC, Warrell MJ, Rupprecht CE, Ertl HC, Dietzschold B, O'reilly M, et al. Management of rabies in humans. Clin Infect Dis. 2003;36(1):60-3.
[6] Hemachudha T., Wacharapluesadee S., Laothamatas J., H. W. Rabies. Curr Neurol Neurosci Rep. 2006;6(6):460-8.
[7] Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, Shuangshoti S, Laothamatas J. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neuro. 2013;12(5):498-513.
[8] Mader Jr EC, Maury JS, Santana-Gould L, Craver RD, El-Abassi R, Segura-Palacios E, et al. Human rabies with initial manifestations that mimic acute brachial neuritis and Guillain-Barré syndrome. Clin Med Insights Case Rep. 2012;5:49.
[9] Mitrabhakdi E, Shuangshoti S, Wannakrairot P, Lewis RA, Susuki K, Laothamatas J, et al. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. J Neurol Sci. 2005;238(1):3-10.
[10] FOOKS AR, FINNEGAN C, JOHNSON N, MANSFIELD K, MCELHINNEY L, MANSER P. Human case of EBL type 2 following exposure to bats in Angus, Scotland. Vet Rec. 2002;151(22):679-.
[11] Feder HM, Petersen BW, Robertson KL, Rupprecht CE. Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts. Curr Infect Dis Rep. 2012;14(4):408-22.
[12] Lafon M. Evasive strategies in rabies virus infection. Adv Virus Res. 2011;79:33.
[13] Gosztonyi G, Ludwig H. Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons. The Mechanisms of Neuronal Damage in Virus Infections of the Nervous System: Springer; 2001. p. 121-44.
IssueVol 8 No 1 (2022): Winter QRcode
SectionCase Report(s)
Sedation-paralysis Rabies Milwaukee protocol

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Jabbari A, Khodabakhshi B, Tabasi S. Sedation-Paralysis as Cornerstone on Rabies Management (Milwaukee Protocol). Arch Anesth & Crit Care. 2022;8(1):83-86.